MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-03+29,000→ 29,000 totalExercise: $7.58From: 2020-01-03Exp: 2029-01-03→ Common Stock (29,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.